Citation Impact
Citing Papers
Comparative analysis reveals no consistent association between the secondary structure of the 3′-untranslated region of dengue viruses and disease syndrome
2006
CRISPR–Cas9 Structures and Mechanisms
2017 StandoutNobel
Cell entry mechanisms of SARS-CoV-2
2020 Standout
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
2020 StandoutScienceNobel
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
2015 StandoutNatureNobel
CRISPR/Cas9-Derived Mutations Both Inhibit HIV-1 Replication and Accelerate Viral Escape
2016
Guide-bound structures of an RNA-targeting A-cleaving CRISPR–Cas13a enzyme
2017 StandoutNobel
Scoring functions for protein–protein interactions
2013 StandoutNobel
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
2016 StandoutNature
Natural attenuation of dengue virus type-2 after a series of island outbreaks: A retrospective phylogenetic study of events in the South Pacific three decades ago
2010
Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity
2020 StandoutNobel
Evolution in Our Understanding of Hepatitis B Virus Virology and Immunology
2016
Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatment
2015
Genome-Editing Technologies: Principles and Applications
2016
Defective Interfering Viral Particles in Acute Dengue Infections
2011
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection
2018 StandoutNobel
Receptors and routes of dengue virus entry into the host cells
2015
Molecular evolution and phylogeny of dengue type 4 virus in the caribbean
2003
New CRISPR–Cas systems from uncultivated microbes
2016 StandoutNatureNobel
Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication
2015
Hepatitis B virus infection
2009 Standout
Structures of the Zika Virus Envelope Protein and Its Complex with a Flavivirus Broadly Protective Antibody
2016
Immature Dengue Virus: A Veiled Pathogen?
2010
El dengue y el dengue hemorrágico: prioridades de investigación
2006
Off-target Effects in CRISPR/Cas9-mediated Genome Engineering
2015 Standout
Dengue: a continuing global threat
2010 Standout
Therapeutic genome editing: prospects and challenges
2015
Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR/Cas RNA-guided DNA endonuclease
2014
In vivo targeted single-nucleotide editing in zebrafish
2018
Search-and-replace genome editing without double-strand breaks or donor DNA
2019 StandoutNature
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
2020 Standout
Bridge helix arginines play a critical role in Cas9 sensitivity to mismatches
2020 StandoutNobel
Dengue
2012 Standout
Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody
2009
Applications of CRISPR technologies in research and beyond
2016 StandoutNobel
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
2015 StandoutNobel
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells
2015
Dual gRNAs guided CRISPR/Cas9 system inhibits hepatitis B virus replication
2015
Alphavirus Mutator Variants Present Host-Specific Defects and Attenuation in Mammalian and Insect Models
2014
Advances in therapeutic CRISPR/Cas9 genome editing
2015
Refining the Global Spatial Limits of Dengue Virus Transmission by Evidence-Based Consensus
2012 Standout
Generation of a reporter yellow fever virus for high throughput antiviral assays
2020 StandoutNobel
The Biology of CRISPR-Cas: Backward and Forward
2018 StandoutNobel
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
2016 Standout
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity
2010
Dengue virus life cycle: viral and host factors modulating infectivity
2010 Standout
CasX enzymes comprise a distinct family of RNA-guided genome editors
2019 StandoutNatureNobel
Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms
2011
Antibody-mediated neutralization of flaviviruses: A reductionist view
2011
Molecular evolution of dengue viruses: Contributions of phylogenetics to understanding the history and epidemiology of the preeminent arboviral disease
2009
Dissection of Antibody Specificities Induced by Yellow Fever Vaccination
2013
The origin, emergence and evolutionary genetics of dengue virus
2003
Economic and Disease Burden of Dengue in Southeast Asia
2013 Standout
Genome-editing Technologies for Gene and Cell Therapy
2016
Dengue
2007 Standout
The Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and Immunoprophylaxis
2017
CRISPR‐Cas9 systems: versatile cancer modelling platforms and promising therapeutic strategies
2015
Redesign of a cross-reactive antibody to dengue virus with broad-spectrum activity and increased in vivo potency
2013
Loss of Sendai virus C protein leads to accumulation of RIG-I immunostimulatory defective interfering RNA
2017 StandoutNobel
Utility of Humanized BLT Mice for Analysis of Dengue Virus Infection and Antiviral Drug Testing
2013 StandoutNobel
Inhibition of hepatitis B virus by the CRISPR/Cas9 system via targeting the conserved regions of the viral genome
2015
Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9
2015
Human genetic variation alters CRISPR-Cas9 on- and off-targeting specificity at therapeutically implicated loci
2017
Fc receptors in antibody‐dependent enhancement of viral infections
2015
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
Conditional Recruitment to a DNA-Bound CRISPR–Cas Complex Using a Colocalization-Dependent Protein Switch
2020 StandoutNobel
The Human Antibody Response to Dengue Virus Infection
2011
Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
2010 Science
CRISPR-Cas: biology, mechanisms and relevance
2016 StandoutNobel
Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
2019 Standout
CRISPR/Cas9 for Human Genome Engineering and Disease Research
2016
Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus
2016
Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity
2016
Analysis of Intrahost Variation in Venezuelan Equine Encephalitis Virus Reveals Repeated Deletions in the 6-Kilodalton Protein Gene
2011
Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus
2014 StandoutNobel
CRISPR-Cas9–based treatment of myocilin-associated glaucoma
2017
Recent Advances in Deciphering Viral and Host Determinants of Dengue Virus Replication and Pathogenesis
2006
Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery
2017 StandoutNobel
Hepatitis B Virus Replication and Liver Disease Progression: The Impact of Antiviral Therapy
2006
CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy
2018
Immune Response to Dengue Virus and Prospects for a Vaccine
2011
Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody
2020 StandoutNobel
Inter- and intra-variant genetic heterogeneity of human coronavirus OC43 strains in France
2006
CRISPR-Cas in Streptococcus pyogenes
2019 StandoutNobel
New Methods in Tissue Engineering: Improved Models for Viral Infection
2014 StandoutNobel
Nontoxic nanopore electroporation for effective intracellular delivery of biological macromolecules
2019 StandoutNobel
Works of Su-Ru Lin being referenced
Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II
2008
The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo
2014
Evolution of Dengue Virus Type 2 during Two Consecutive Outbreaks with an Increase in Severity in Southern Taiwan in 2001–2002
2008
48 Interferon therapy reduces cirrhosis and hepatocellular carcinoma in HBeAg positive chronic hepatitis B
2006
Study of Sequence Variation of Dengue Type 3 Virus in Naturally Infected Mosquitoes and Human Hosts: Implications for Transmission and Evolution
2004
Dengue Type 3 Virus in Plasma Is a Population of Closely Related Genomes: Quasispecies
2002